- Home
- EFSC vs ARQT Comparison
EFSC vs ARQT Comparison
Compare EFSC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- ARQT
- Stock Information
- Founded
- EFSC 1988
- ARQT 2016
- Country
- EFSC United States
- ARQT United States
- Employees
- EFSC N/A
- ARQT N/A
- Industry
- EFSC Major Banks
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- EFSC Finance
- ARQT Health Care
- Exchange
- EFSC Nasdaq
- ARQT Nasdaq
- Market Cap
- EFSC 2.0B
- ARQT 2.0B
- IPO Year
- EFSC 1999
- ARQT 2020
- Fundamental
- Price
- EFSC $48.60
- ARQT $13.01
- Analyst Decision
- EFSC Strong Buy
- ARQT Strong Buy
- Analyst Count
- EFSC 3
- ARQT 6
- Target Price
- EFSC $67.33
- ARQT $18.80
- AVG Volume (30 Days)
- EFSC 362.1K
- ARQT 2.6M
- Earning Date
- EFSC 04-28-2025
- ARQT 05-06-2025
- Dividend Yield
- EFSC 2.26%
- ARQT N/A
- EPS Growth
- EFSC N/A
- ARQT N/A
- EPS
- EFSC 4.83
- ARQT N/A
- Revenue
- EFSC $607,337,000.00
- ARQT $196,542,000.00
- Revenue This Year
- EFSC $10.66
- ARQT $60.21
- Revenue Next Year
- EFSC $2.14
- ARQT $40.21
- P/E Ratio
- EFSC $10.08
- ARQT N/A
- Revenue Growth
- EFSC 3.73
- ARQT 229.74
- 52 Week Low
- EFSC $37.28
- ARQT $6.99
- 52 Week High
- EFSC $63.13
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- EFSC 38.33
- ARQT 41.36
- Support Level
- EFSC $45.22
- ARQT $12.51
- Resistance Level
- EFSC $48.27
- ARQT $13.67
- Average True Range (ATR)
- EFSC 2.17
- ARQT 1.45
- MACD
- EFSC -0.06
- ARQT -0.32
- Stochastic Oscillator
- EFSC 37.06
- ARQT 20.65
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.